NASDAQ:BBIO | Net Income | BridgeBio Pharma, Inc.

Complete source-backed net income history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Net Income

DateNet Income
2026-06-30-$155.89M
2026-03-31-$166.56M
2025-12-31-$194.64M
2025-09-30-$184.94M
2025-06-30-$183.76M
2025-03-31-$169.61M
2024-12-31-$267.39M
2024-09-30-$164.25M
2024-06-30-$75.54M
2024-03-31-$36.16M
2023-12-31-$170.33M
2023-09-30-$179.49M
2023-06-30-$160.7M
2023-03-31-$142.73M
2022-12-31-$140.57M
2022-09-30-$140.19M
2022-06-30-$2.56M
2022-03-31-$201.33M
2021-12-31-$152.28M
2021-09-30-$161.02M
2021-06-30-$102.07M
2021-03-31-$171.08M
2020-12-31-$135.03M
2020-09-30-$130.17M
2020-06-30-$136.21M
2020-03-31-$104.08M
2019-12-31-$84.15M
2019-09-30-$60.66M
2019-06-30-$74.33M
2019-03-31-$69.44M
2018-12-31-$49.24M
2018-09-30-$42.08M

Annual Net Income

DateNet Income
2025-12-31-$732.94M
2024-12-31-$543.35M
2023-12-31-$653.25M
2022-12-31-$484.65M
2021-12-31-$586.45M
2020-12-31-$505.49M
2019-12-31-$288.59M
2018-12-31-$169.45M
2017-12-31-$43.83M